MedTrace Logo

Vitamin D With Omega-3 or Metformin in Osteoarthritis

NCT06328426 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2024-03-25

No results posted yet for this study

Summary

To determine the efficacy of vitamin D with omega-3 or metformin for reducing knee symptoms and effusion synovitis in patients with symptomatic knee osteoarthritis.

Conditions

Interventions

DIETARY_SUPPLEMENT

Vitamin D

The dose of Vitamin D will be 1000 IU /day taken orally. The duration of the intervention will be 4 months.

DIETARY_SUPPLEMENT

Omega-3

The dose of omega-3 will be 1000 mg /day taken orally. The duration of the intervention will be 4 months.

DRUG

Metformin

The dose of metformin will be 1000 IU /day taken orally. The duration of the intervention will be 4 months.

DIETARY_SUPPLEMENT

Placebo

The duration of the intervention will be 4 months.

Sponsors & Collaborators

  • Assiut University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
40 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-08-31
Primary Completion
2026-08-31
Completion
2026-12-31

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06328426 on ClinicalTrials.gov